galantamine has been researched along with cotinine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Adam, BL; Gao, J; Terry, AV | 1 |
Curtis, MA; Lin, SX; Sperry, J | 1 |
Batra, A; Croissant, B; Diehl, A; Mann, K; Nakovics, H; Smolka, MN | 1 |
Brede, E; MacLean, RR; Sofuoglu, M; Waters, AJ | 1 |
1 review(s) available for galantamine and cotinine
Article | Year |
---|---|
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
2 trial(s) available for galantamine and cotinine
Article | Year |
---|---|
Galantamine reduces smoking in alcohol-dependent patients: a randomized, placebo-controlled trial.
Topics: Administration, Cutaneous; Adult; Alcoholism; Cholinesterase Inhibitors; Cotinine; Double-Blind Method; Female; Galantamine; Humans; Male; Middle Aged; Nicotine; Patient Compliance; Sex Factors; Skin Diseases; Smoking; Smoking Cessation; Smoking Prevention; Time Factors; Tobacco Use Disorder; Treatment Outcome | 2006 |
Effects of galantamine on smoking behavior and cognitive performance in treatment-seeking smokers prior to a quit attempt.
Topics: Adult; Cholinesterase Inhibitors; Cognition; Cotinine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Galantamine; Humans; Male; Nootropic Agents; Patient Acceptance of Health Care; Patient Satisfaction; Smokers; Smoking; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome | 2018 |
2 other study(ies) available for galantamine and cotinine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cotinine; Humans; Neurons; Neuroprotective Agents; Nicotine; Peptide Fragments; Rats; Receptors, N-Methyl-D-Aspartate | 2014 |